Cholesterol as a factor regulating the influence of natural (PAF and lysoPAF) vs synthetic (ED) ether lipids on model lipid membranes

Biochimica et Biophysica Acta - Biomembranes

Volumn 1828, Issue 11, 2013, Pages 2700-2708

  Flasiński, Michał ^a   Wydro, Paweł ^a   Ha̧c Wydro, Katarzyna ^a   Dynarowicz ŁA̧tka, Patrycja ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Anticancer effect; Ether lipid Langmuir monolayer; Monolayer condensation

Indexed keywords

1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE; CHOLESTEROL; EDELFOSINE; GANGLIOSIDE; STEROL; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CHEMICAL STRUCTURE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; LIPID MEMBRANE; LIPID MONOLAYER; MISCIBILITY; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION;

ANTICANCER EFFECT; ETHER LIPID; LANGMUIR MONOLAYER; MONOLAYER CONDENSATION;

CHOLESTEROL; ETHER; MEMBRANE LIPIDS; MEMBRANES, ARTIFICIAL; PHOSPHATIDYLCHOLINES; PLATELET ACTIVATING FACTOR;

EID: 84881508924     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2013.07.024     Document Type: Article

References (48)

1. C. Gajate, and F. Mollinedo Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH3 (Edelfosine), a proapoptotic agent in tumor cells Curr. Drug Metab. 3 2002 491 525
2. W.J. van Blitterswijk, and M. Verheij Anticancer mechanisms and clinical application of alkylphospholipids Biochim. Biophys. Acta 1831 2013 663 674
3. F. Mollinedo, and C. Gajate Lipid rafts, death receptors and CASMERs: new insights for cancer therapy Future Oncol. 6 2010 491 494
4. T. Nieto-Miguel, R.I. Fonteriz, L. Vay, C. Gajate, S. Lopez-Hernandez, and F. Mollinedo Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells Cancer Res. 1 2007 10368 10378
5. F. Mollinedo, J. de la Iglesia-Vicente, C. Gajate, A. Estella-Hermoso de Mendoza, J.A. Villa-Pulgarin, M. de Frias, G. Roué, J. Gil, D. Colomer, M.A. Campanero, and M.J. Blanco-Prieto In vitro and In vivo selective antitumor activity of edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts Clin. Cancer Res. 16 2010 2046 2054
6. M. Dymond, G. Attard, and A.D. Postle Testing the hypothesis that amphiphilic antineoplastic lipid analogues act through reduction of membrane curvature elastic stress J. R. Soc. Interface 5 2008 1371 1386
7. A.B. Gomide, C.H. Thomé, G.A. dos Santos, G.A. Ferreira, V.M. Faça, E.M. Rego, L.J. Greene, R.G. Stabeli, P. Ciancaglini, and R. Itri Disrupting membrane raft domains by alkylphospholipids Biochim. Biophys. Acta 1828 2013 1384 1389
8. M. Potier, A. Chantome, V. Joulin, A. Girault, S. Roger, P. Besson, M.-L. Jourdan, J.-Y. LeGuennec, P. Bougnoux, and C. Vandier The SK3/KCa2.3 potassium channel is a new cellular target for edelfosine Br. J. Pharmacol. 162 2011 464 479
9. B.A. Wagner, G.R. Buettner, L.W. Oberley, and C.P. Burns Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species Cancer Res. 58 1998 2809 2816
10. A. Estella-Hermoso de Mendoza, M.A. Campanero, J. De la Iglesia-Vicente, C. Gajate, F. Mollinedo, and M.J. Blanco-Prieto Anti-tumour alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behaviour in healthy and tumour-bearing immune suppressed mice Cancer Res. 15 2009 858 864
11. H.K. Na, and Y.J. Surh The antitumor ether lipid edelfosine (ET-18-O-CH3) induces apoptosis in H-ras transformed human breast epithelial cells: by blocking ERK1/2 and p38 mitogenactivated protein kinases as potential targets Asia Pac. J. Clin. Nutr. 17 2008 204 207
12. S.H. Shafer, and C.L. Williams Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment Int. J. Oncol. 23 2003 389 400
13. M.C. Chabot, R.L. Wykle, E.J. Modest, and L.W. Daniel Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine Cancer Res. 49 1989 4441 4445
14. M.I. Gurr, J.L. Harwood, and K.N. Frayn Lipid Biochemistry 5th edition 2002 Blackwell Science Ltd
15. F. Snyder, T.-Ch Lee, and R.L. Wykle Ether-linked lipids and their bioactive species D.E. Vance, J.E. Vance, Biochemistry of Lipids, Lipoproteins and Membranes 4th edition 2002 (chapter 9)
16. R. Göggel, and S. Uhlig The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema Eur. Respir. J. 25 2005 849 857
17. L. Kemeny, V. Trach, and A. Dobozy Effect of locally applied WEB 2086, a platelet-activating factor antagonist, on inflammatory skin conditions in mice Arch. Dermatol. Res. 288 1996 492 494
18. G. Montrucchio, G. Alloatti, and G. Camussi Role of platelet-activating factor in cardiovascular pathophysiology Physiol. Rev. 80 2000 1669 1700
19. E.J. Welch, R.P. Naikawadi, Z. Li, P. Lin, S. Ishii, T. Shimizu, C. Tirupphathi, X. Du, P.V. Subbaiah, and R.D. Ye Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation Mol. Pharmacol. 75 2009 227 234
20. L. Mrówczyńska, and H. Hagerstrand Platelet-activating factor interaction with the human erythrocyte membrane J. Biochem. Mol. Toxicol. 23 2009 345 348
21. A. Kantar, P.L. Giorgi, G. Curatola, and R. Fiorini Effect of PAF on erythrocyte membrane heterogeneity: a fluorescence study Agents Actions 32 1991 347 350
22. A. Kantar, P.L. Giorgi, and R. Fiorini Effect of PAF on human lymphocyte membranes: a fluorescence study Agents Actions 38 1993 C115 C117 (Spec. No.)
23. J. Chen, L. Yang, J.M. Foulks, A.S. Weyrich, G.K. Marathe, and T.M. McIntyre Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis J. Lipid Res. 48 2007 2365 2376
24. K. Danker, W. Reutter, and G. Semini Glycosidated phospholipids: uncoupling of signaling pathways at the plasma membrane Br. J. Pharmacol. 160 2010 36 47
25. I. Kudo, I.S. Nojima, H.W. Chang, R. Yanoshita, H. Hayashi, E. Kondo, H. Nomura, and K. Inoue Antitumor activity of synthetic alkylphospholipids with or without PAF activity Lipids 22 1987 862 867
26. A. Wiȩcek, P. Dynarowicz-Ła̧tka, N. Vila-Romeu, M. Nieto-Suarez, and M. Flasiński Interactions between an anticancer drug - edelfosine - and DPPC in Langmuir monolayers Colloids Surf. A 321 2008 201 205
27. K. Ha̧c-Wydro, and P. Dynarowicz-Ła̧tka Effect of edelfosine on tumor and normal cells model membranes - a comparative studies Colloids Surf. B 76 2010 366 369
28. M. Flasiński, M. Broniatowski, P. Wydro, K. Ha̧c-Wydro, and P. Dynarowicz-Ła̧tka Behavior of platelet activating factor in membrane-mimicking environment. Langmuir monolayer study complemented with grazing incidence x-ray diffraction and Brewster angle microscopy J. Phys. Chem. B 116 2012 10842 10855
29. K. Ha̧c-Wydro, M. Flasiński, P. Wydro, and P. Dynarowicz-Ła̧tka Towards the understanding of the behavior of single-chained ether phospholipids in model biomembranes: interactions with phosphatidylethanolamines in Langmuir monolayers Colloids Surf. B 97 2012 162 170
30. L. Diomede, A. Bizzi, A. Magistrelli, E.J. Modest, M. Salmona, and A. Noseda Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity Int. J. Cancer 46 1990 34 346
31. L. Diomede, B. Piovani, E.J. Modest, and M. Salmona The effect of culture medium composition on ether lipid cytotoxic activity Lipids 28 1993 189 192
32. M. Levi, P. Wilson, S. Nguyen, E. Iorio, O. Sapora, and T. Parasassi In K562 and HL60 cells membrane ageing during cell growth is associated with changes in cholesterol concentration Mech. Ageing Dev. 97 1997 109 119
33. I.S. Costin, and G.T. Barnes Two-component monolayers. II. Surface pressure-area relations for the octadecanoi-docosyl sulphate system J. Colloid Interface Sci. 51 1975 106 121
34. P. Wydro, S. Knapczyk, and M. Łapczyńska Variations in the condensing effect of cholesterol on saturated versus unsaturated phosphatidylcholines at low and high sterol concentration Langmuir 27 2011 5433 5444
35. T.H. Chou, and Ch.H. Chang Thermodynamic behavior and relaxation processes of mixed DPPC/cholesterol monolayers at the air/water interface Colloids Surf. B 17 2000 71 79
36. K. Gong, S.S. Feng, M.L. Go, and P.H. Soew Effects of pH on the stability and compressibility of DPPC/cholesterol monolayers at the air/water interface Colloids Surf. A 207 2002 113 125
37. Y. Gu, J. Zhang, W. Mi, J. Yang, F. Han, X. Lu, and W. Yu Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells Breast Cancer Res. 10 2008 R1 (1)
38. R.G. Fish Role of gangliosides in tumor progression: a molecular target for cancer therapy? Med. Hypotheses 46 1996 140 144
39. G. Marquina, H. Waki, L.E. Fernandez, K. Kon, A. Carr, O. Valiente, R. Perez, and S. Ando Gangliosides expressed in human breast cancer Cancer Res. 56 1996 5165 5171
40. T.N. Seyfried, and P. Mukherjee Ganglioside GM3 is antiangiogenic in malignant brain cancer J. Oncol. 2010 2010 961243 10.1155/2010/961243
41. R. Fuentes, R. Allman, and M.D. Mason Ganglioside expression in lung cancer cell lines Lung Cancer 18 1997 21 33
42. M. Flasiński, K. Ha̧c-Wydro, P. Wydro, M. Broniatowski, and P. Dynarowicz-Ła̧tka Interactions between single-chained ether phospholipids and sphingomyelin in mixed monolayers at the air/water interface-Grazing incidence X-ray diffraction and Brewster angle microscopy studies Colloids Surf. B 111 2013 43 51
43. A. Wiȩcek, P. Dynarowicz-Ła̧tka, J. Miñones Jr., O. Conde, and M. Casas Interactions between an anticancer drug - edelfosine - and cholesterol in Langmuir monolayers Thin Solid Films 516 2008 8829 8833
44. M. Rodrigues, A. Santos, B.G. de la Torre, G. Radis-Baptista, D. Andreu, and N.C. Santos Molecular characterization of the interactions of crotamine-derived nucleolar targeting peptide with lipid membranes Biochim. Biophys. Acta 1818 2012 2707 2717
45. + ions: the Langmuir technique study Biochim. Biophys. Acta 1808 2011 2706 2713
46. M. Flasiński, M. Broniatowski, P. Wydro, and P. Dynarowicz-Ła̧tka Comparative characteristics of membrane-active single-chained ether phospholipids: PAF and Lyso-PAF in Langmuir monolayers J. Phys. Chem. B 116 2012 3155 3163
47. J. Majewski, T.L. Kuhl, K. Kjaer, and G.S. Smith Packing of ganglioside-phospholipid monolayers: an x-ray diffraction and reflectivity study Biophys. J. 81 2001 2707 2715
48. P. Wydro, and K. Ha̧c-Wydro Thermodynamic description of the interactions between lipids in ternary Langmuir monolayers: the study of cholesterol distribution in membranes J. Phys. Chem. B 111 2007 2495 2502